Abstract
Background
Patients with Inflammatory bowel disease (IBD) are susceptible to psychiatric co-morbidities. We aimed to ascertain the burden of anxiety, depression, and perceived stress in patients with IBD from north India.
Methods
Consenting adult patients with an established diagnosis of IBD were enrolled. The enrolled patients filled the Hospital Anxiety and Depression Scale (HADS) and Perceived Stress Scale (PSS) questionnaires. The patient and disease characteristics were analyzed to determine the correlations and predictors of psychiatric comorbidities.
Results
A total of 318 patients (255 UC, 63 CD; mean age 40.13 ± 12.06 years, 168 [52.8%] males; mean partial Mayo score 2.10 ± 2.35; and mean HBI 2.77 ± 2.13) were enrolled. The prevalence of anxiety, depression and moderate to high perceived stress was 14%, 12%, and 41%, respectively. Females had higher mean perceived stress, anxiety and depression scores compared to males. The partial Mayo score (PMS) correlated poorly with anxiety (ρ = 0.083, p = 0.187), depression (ρ = 0.123, p = 0.49) and perceived stress (ρ = 0.169; p = 0.007). The Harvey Bradshaw index (HBI) correlated fairly with anxiety (ρ = 0.336, p = 0.007) and poorly with depression (ρ = 0.287, p = 0.022) and perceived stress (ρ = 0.20; p = 0.117). Younger age (OR 0.93, 95% CI 0.90–0.97; p = 0.001) and hand-grip strength (OR 4.63, 95% CI 1.88–11.42; p = 0.001) predicted anxiety in patients with UC while rural area of residence (OR 4.75, 95% CI 1.03–21.98; p = 0.046) and HBI (OR 1.60, 95% CI 1.12–2.29; p = 0.009) were significant predictors of anxiety in patients with CD.
Conclusion
Psychiatric comorbidities are common in patients with IBD, with higher prevalence in females. Young adults with UC and sarcopenia; and individuals with active CD living in rural areas are at an increased risk of anxiety.
Graphical Abstract
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author, [AS], upon reasonable request.
References
Lee SH, eun Kwon J, Cho ML. Immunological pathogenesis of inflammatory bowel disease. Intest Res 2018;16:26–42.
von Wietersheim J, Kessler H. Psychotherapy with chronic inflammatory bowel disease patients: a review. Inflammatory Bowel Diseases. 2006;12:1175–1184.
Graff LA, Walker JR, Lix L, Clara I, Rawsthorne P, Rogala L et al. The Relationship of Inflammatory Bowel Disease Type and Activity to Psychological Functioning and Quality of Life. Clin Gastroenterol Hepatol 2006;4:1491–1501.e1.
Lukas M. Inflammatory bowel disease as a risk factor for colorectal cancer. Dig Dis 2010;28:619–624.
Hu S, Chen Y, Chen Y, Wang C. Depression and anxiety disorders in patients with inflammatory bowel disease. Front Psychiatr 2021;8:714057.
Choi K, Chun J, Han K, Park S, Soh H, Kim J et al. Risk of anxiety and depression in patients with inflammatory bowel disease: a nationwide, population-based study. J Clin Med 2019;8:E654.
Walker JR, Ediger JP, Graff LA, Greenfeld JM, Clara I, Lix L, et al. The Manitoba IBD Cohort Study: A Population-Based Study of the Prevalence of Lifetime and 12-Month Anxiety and Mood Disorders. Off J Am Coll Gastroenterol | ACG. 2008 Aug;103:1989.
Targownik LE, Sexton KA, Bernstein MT, Beatie B, Sargent M, Walker JR, et al. The Relationship Among Perceived Stress, Symptoms, and Inflammation in Persons With Inflammatory Bowel Disease. Off J Am Coll Gastroenterol | ACG. 2015 Jul;110:1001.
Marrie RA, Graff LA, Fisk JD, Patten SB, Bernstein CN, the CIHR Team in Defining the Burden and Mitigating the Impact of Psychiatric Comorbidity in Immuno-inflammatory Disease. The Relationship between symptoms of depression and anxiety and disease activity in IBD over time. Inflamm Bowel Dis 2021;27:1285–93.
Persoons P, Vermeire S, Demyttenaere K, Fischler B, Vandenberghe J, Van Oudenhove L et al. The impact of major depressive disorder on the short- and long-term outcome of Crohn’s disease treatment with infliximab. Aliment Pharmacol Ther 2005;22:101–110.
Iglesias-Rey M, Barreiro-de Acosta M, Caamaño-Isorna F, Rodríguez IV, Ferreiro R, Lindkvist B et al. Psychological factors are associated with changes in the health-related quality of life in inflammatory bowel disease. Inflamm Bowel Dis 2014;20:92–102.
Bernstein CN, Singh S, Graff LA, Walker JR, Miller N, Cheang M. A prospective population-based study of triggers of symptomatic flares in IBD. Off J Am Coll Gastroenterol | ACG. 2010 Sep;105:1994.
Fairbrass KM, Lovatt J, Barberio B, Yuan Y, Gracie DJ, Ford AC. Bidirectional brain–gut axis effects influence mood and prognosis in IBD: a systematic review and meta-analysis. Gut 2022;71:1773–1780.
IsHak WW, Pan D, Steiner AJ, Feldman E, Mann A, Mirocha J et al. Patient-reported outcomes of quality of life, functioning, and GI/Psychiatric symptom severity in patients with inflammatory bowel disease (IBD). Inflamm Bowel Dis 2017;23:798–803.
Williet N, Sandborn WJ, Peyrin-Biroulet L. Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease. Clin Gastroenterol Hepatol 2014;12:1246-1256.e6.
Yanartas O, Kani H, Bicakci E, Kilic I, Banzragch M, Acikel C et al. The effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease. Neuropsychiatr Dis Treat 2016;24:673–683.
Peyrin-Biroulet L, Sandborn W, Sands BE, Reinisch W, Bemelman W, Bryant RV, et al. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target. Off J Am Coll Gastroenterol | ACG. 2015 Sep;110:1324.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–370.
Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385–396.
Maaser C, Sturm A, Vavricka SR, Kucharzik T, Fiorino G, Annese V et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J Crohn’s Colitis 2019;13:144–164K.
Lewis JD, Chuai S, Nessel L, Lichtenstein GR, Aberra FN, Ellenberg JH. Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis. Inflamm Bowel Dis 2008;14:1660–1666.
Harvey R, Bradshaw MJ. Measuring Crohn's Disease ActivityThe Lancet 1980;315:1134–1135.
Mukaka M. A guide to appropriate use of correlation coefficient in medical research. Malawi Med J 2012;24:69–71.
Barberio B, Zamani M, Black CJ, Savarino EV, Ford AC. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2021;6:359–370.
Mikocka-Walus A, Knowles SR, Keefer L, Graff L. Controversies Revisited: A systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases. Inflamm Bowel Dis 2016;22:752–762.
Neuendorf R, Harding A, Stello N, Hanes D, Wahbeh H. Depression and anxiety in patients with inflammatory bowel disease: a systematic review. J Psychosom Res 2016;1:70–80.
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatr. 2022 Feb 1;9:137–50.
Avasthi A. Preserve and strengthen family to promote mental health. Indian J Psychiatr 2010;52:113–126.
Barberio B, Zamani M, Black CJ, Savarino EV, Ford AC. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2021;6:359–370.
Maconi G, Gridavilla D, Viganò C, Sciurti R, Asthana AK, Furfaro F et al. Perianal disease is associated with psychiatric co-morbidity in Crohn’s disease in remission. Int J Colorectal Dis 2014;29:1285–1290.
Janke KH, Klump B, Gregor M, Meisner C, Haeuser W. Determinants of life satisfaction in inflammatory bowel disease. Inflamm Bowel Dis 2005;11:272–286.
Arp L, Jansson S, Wewer V, Burisch J. Psychiatric disorders in adult and paediatric patients with inflammatory bowel diseases – a systematic review and meta-analysis. J Crohn’s Colitis. 2022;16:1933–1945.
Navabi S, Gorrepati VS, Yadav S, Chintanaboina J, Maher S, Demuth P et al. Influences and impact of anxiety and depression in the setting of inflammatory bowel disease. Inflamm Bowel Dis 2018;24:2303–2308.
Dhaliwal A, Quinlan JI, Overthrow K, Greig C, Lord JM et al. Sarcopenia in inflammatory bowel disease: a narrative overview. Nutrients 2021;13:656.
Goodman WA, Erkkila IP, Pizarro TT. Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2020;17:740–754.
Lungaro L, Costanzini A, Manza F, Barbalinardo M, Gentili D, Guarino M et al. Impact of female gender in inflammatory bowel diseases: a narrative review. J Pers Med 2023;13:165.
Bannaga AS, Selinger CP. Inflammatory bowel disease and anxiety: links, risks, and challenges faced. Clini Exp Gastroenterol 2015;31:111–117.
van den Brink G, Stapersma L, Vlug LE, Rizopolous D, Bodelier AG, van Wering H et al. Clinical disease activity is associated with anxiety and depressive symptoms in adolescents and young adults with inflammatory bowel disease. Aliment Pharmacol Ther 2018;48:358–369.
Qualter P, Rouncefield-Swales A, Bray L, Blake L, Allen S, Probert C et al. Depression, anxiety, and loneliness among adolescents and young adults with IBD in the UK: the role of disease severity, age of onset, and embarrassment of the condition. Qual Life Res 2021;30:497–506.
Schoevers RA, Beekman ATF, Deeg DJH, Geerlings MI, Jonker C, Van Tilburg W. Risk factors for depression in later life; results of a prospective community based study (AMSTEL). J Affect Disord 2000;59:127–137.
Singh A, Midha V, Mahajan R, Verma S, Kakkar C, Grover J et al. Evaluation of nutritional characteristics reveals similar prevalence of malnutrition in patients with ulcerative colitis and Crohn’s disease. Dig Dis Sci 2023;68:580–595. https://doi.org/10.1007/s10620-022-07652-z
West EC, Williams LJ, Corney KB, Pasco JA. Is sarcopenia associated with anxiety symptoms and disorders? A systematic review and meta-analysis protocol. BMJ Open 2021;11:e054125.
Gunjan Kumar, Dash P, Jayeshmit Patnaik, Gitanjali Pany. SOCIOECONOMIC STATUS SCALE-MODIFIED KUPPUSWAMY SCALE FOR THE YEAR 2022. IJCD. 2022 Jun 10;10:1–6.
Butler TL, Fraser GE, Beeson WL, Knutsen SF, Herring RP, Chan J et al. Cohort profile: the adventist health study-2 (AHS-2). Int J Epidemiol 2008;37:260–265.
Funding
Nil.
Author information
Authors and Affiliations
Contributions
AS: Conception and design of the study, acquisition of data, interpretation of data, drafting the article, revising it critically for important intellectual content, final approval of the version to be submitted. AB: Interpretation of data, drafting the article, revising the article critically for important intellectual content, final approval of the version to be submitted. AT: Acquisition of data, final approval of the version to be submitted. MKR: Revising the article critically for important intellectual content, final approval of the version to be submitted. DS: Acquisition of data, final approval of the version to be submitted. AS: Revising the article critically for important intellectual content, final approval of the version to be submitted. MM: Revising the article critically for important intellectual content, final approval of the version to be submitted. KSS: Revising the article critically for important intellectual content, final approval of the version to be submitted. NB: Interpretation of data, final approval of the version to be submitted. RM: Revising the article critically for important intellectual content, final approval of the version to be submitted. KK: Revising the article critically for important intellectual content, final approval of the version to be submitted. VM: Conceptualization, Supervision, Project administration, Drafting the article, revising it critically for important intellectual content, final approval of the version to be submitted. AS: Conception and design of the study, acquisition of data, interpretation of data, drafting the article, revising it critically for important intellectual content, final approval of the version to be submitted.
Corresponding author
Ethics declarations
Conflict of interest
Ajit Sood is on the advisory board of Janssen Pharmaceuticals (Asia–Pacific) and received honorarium for speaker events from Pfizer India and Takeda India. The remaining authors disclose no conflicts.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Singh, A., Bhardwaj, A., Tripathi, A. et al. Burden of Anxiety, Depression and Perceived Stress in Patients with Inflammatory Bowel Disease: A Cohort Study from North India. Dig Dis Sci 69, 775–790 (2024). https://doi.org/10.1007/s10620-023-08242-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-023-08242-3